Organon & Co | OGN - Umsatzerlöse





Der Umsatz Veränderung Datum
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Kangmei Pharma CNY 1.19B 106M 2026-06
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.6B 310M 2026-06
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 13.11B 750M 2026-03
Organigram Holdings CAD 59.79M 3.74M 2026-03
Organon & Co USD 1.56B 100M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Sartorius EUR 926.3M 14.5M 2026-09
Sino Biopharmaceutical CNY 19.44B 5.18B 2026-06
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 34M 34.92M 2026-03